Philip Kohlmann

Ph.D. Student

Kontakt:

PharmaCampus der Westfälischen Wilhelms-Universität Münster
Institut für Pharmazeutische und Medizinische Chemie
Corrensstraße 48
48149 Münster

Tel.: +49 (0)251 83-32203
Raum: A.110.108
E-Mail

Development of novel active pharmaceutical ingredients for the inhibition of protein-protein-interactions with HSP90

Arzneistoffanalytik unter besonderer Berücksichtigung der Arzneibücher (Qualitätskontrolle und -sicherung bei Arzneistoffen)

Paper:

Kohlmann P, Krylov S, Marchand P, Jose J (2024) FRET assays for the identification of C. albicans HSP90-Sba1 and human HSP90α-p23 binding inhibitors, Pharmaceuticals, 17:516
https://doi.org/10.3390/ph17040516, IF: 4.6
Kohlmann P, Stillhart C, Kuentz M, Parrott N. (2017) Investigating Oral Absorption of Carbamazepine in Pediatric Populations. AAPS J
doi: 10.1208/s12248-017-0149-6
Leinonen H, Keksa-Goldsteine V, Ragauskas S, Kohlmann P, Singh Y, Savchenko E, Puranen J, Malm T, Kalesnykas G, Koistinaho J, Tanila H, Kanninen KM. (2017) Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy. Sci Rep
doi: 10.1038/s41598-017-01716-1

Poster:

Kohlmann P, Marchand P, Bazin M-A, Le Pape P, Jose J (2023) Towards new antifungal drugs: A FRET-based assay for the identification of C. albicans Hsp90 and HSP90 - Sba1 interaction inhibitors. ECMC2023 - 9th International Conference on Medicinal Chemistry, 01.-30.11.2023
Kohlmann P, Marchand P, Bazin M-A, Le Pape P, Jose J (2023) A FRET-based HTS assay for the identification and characterization of ATP-competitive HSP90 and HSP90 - p23 interaction inhibitors. EFMC-ISCB2023 - International Symposium on Chemical Biology, Basel, 16.-18.11.2023

Kohlmann P, Marchand P, Bazin M-A, Le Pape P, Jose J (2023) A Novel FRET-based assay for the identification of C. albicans Hsp90 - Sba1 interaction inhibitors. RICT2023 - 57th International Conference on Medicinal Chemistry, Lille, 05.-07.07.2023